Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
Abstract In ART programs in sub-Saharan Africa, a growing proportion of HIV-infected persons initiating first-line antiretroviral therapy (ART) have a history of prior antiretroviral drug use (PAU). We assessed the effect of PAU on the risk of pre-treatment drug resistance (PDR) and virological fail...
Guardado en:
Autores principales: | Seth C. Inzaule, Cissy M. Kityo, Margaret Siwale, Alani Sulaimon Akanmu, Maureen Wellington, Marleen de Jager, Prudence Ive, Kishor Mandaliya, Wendy Stevens, T. Sonia Boender, Pascale Ondoa, Kim C. E. Sigaloff, Denise Naniche, Tobias F. Rinke de Wit, Raph L. Hamers |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0647a6dbb601463f9750fafd510d38ea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
por: Fernandez C, et al.
Publicado: (2019) -
Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data
por: Rock AE, et al.
Publicado: (2020) -
In memory of Vyacheslav F. Lavrov
por: article Editorial
Publicado: (2021) -
Resistencia a la terapia antirretroviral en pacientes infectados con el virus VIH-1 en Chile 2002-2005
por: Afani S,Alejandro, et al.
Publicado: (2007) -
THE EFFECTS OF DENSITY AND PRESS TIME ON POPLAR INSULATION PARTICLEBOARD PROPERTIES
por: Amir Nourbakhsh, et al.
Publicado: (2006)